IL84346A - Antibiotic compositions comprising lyophilized or precipitated cephalosporin zwitterion and salt combination - Google Patents

Antibiotic compositions comprising lyophilized or precipitated cephalosporin zwitterion and salt combination

Info

Publication number
IL84346A
IL84346A IL84346A IL8434687A IL84346A IL 84346 A IL84346 A IL 84346A IL 84346 A IL84346 A IL 84346A IL 8434687 A IL8434687 A IL 8434687A IL 84346 A IL84346 A IL 84346A
Authority
IL
Israel
Prior art keywords
lyophilized
precipitated
antibiotic compositions
salt combination
zwitterion
Prior art date
Application number
IL84346A
Other languages
English (en)
Other versions
IL84346A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL84346A0 publication Critical patent/IL84346A0/xx
Publication of IL84346A publication Critical patent/IL84346A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
IL84346A 1987-01-09 1987-11-02 Antibiotic compositions comprising lyophilized or precipitated cephalosporin zwitterion and salt combination IL84346A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/001,945 US4808617A (en) 1985-12-18 1987-01-09 Lyophilized or precipitated cephalosporin zwitterion and salt combination

Publications (2)

Publication Number Publication Date
IL84346A0 IL84346A0 (en) 1988-04-29
IL84346A true IL84346A (en) 1992-05-25

Family

ID=21698538

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84346A IL84346A (en) 1987-01-09 1987-11-02 Antibiotic compositions comprising lyophilized or precipitated cephalosporin zwitterion and salt combination

Country Status (33)

Country Link
US (1) US4808617A (it)
JP (1) JP2568226B2 (it)
KR (1) KR950010154B1 (it)
AR (1) AR243501A1 (it)
AT (1) AT388672B (it)
AU (1) AU606361B2 (it)
BE (1) BE1002114A3 (it)
CA (1) CA1307464C (it)
CH (1) CH676202A5 (it)
CS (1) CS265249B2 (it)
CY (1) CY1679A (it)
DD (1) DD264614A5 (it)
DE (1) DE3740588C2 (it)
DK (1) DK166404B1 (it)
ES (1) ES2008951A6 (it)
FI (1) FI89006C (it)
FR (1) FR2609396B1 (it)
GB (1) GB2199746B (it)
GR (1) GR871860B (it)
HK (1) HK5593A (it)
HU (1) HU199686B (it)
IE (1) IE61238B1 (it)
IL (1) IL84346A (it)
IT (1) IT1215666B (it)
LU (1) LU87102A1 (it)
NL (1) NL193266C (it)
OA (1) OA08796A (it)
PT (1) PT86157B (it)
SE (1) SE467910B (it)
SG (1) SG114792G (it)
SU (1) SU1575942A3 (it)
YU (1) YU46689B (it)
ZA (1) ZA88114B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2016035846A1 (ja) 2014-09-04 2016-03-10 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953439A (en) * 1973-08-01 1976-04-27 Smithkline Corporation Substituted phenylglycylcephalosporins
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables

Also Published As

Publication number Publication date
IE61238B1 (en) 1994-10-19
NL193266C (nl) 1999-05-06
LU87102A1 (fr) 1988-08-23
IL84346A0 (en) 1988-04-29
NL193266B (nl) 1999-01-04
AT388672B (de) 1989-08-10
AU8085687A (en) 1989-05-11
CS15888A2 (en) 1989-01-12
DK577387A (da) 1988-07-10
KR950010154B1 (ko) 1995-09-11
JP2568226B2 (ja) 1996-12-25
ZA88114B (it) 1988-06-27
KR880008811A (ko) 1988-09-13
IE872970L (en) 1988-07-09
PT86157B (pt) 1991-02-08
DK577387D0 (da) 1987-11-03
PT86157A (en) 1987-12-01
IT8819013A0 (it) 1988-01-07
CA1307464C (en) 1992-09-15
DE3740588A1 (de) 1988-07-21
AR243501A1 (es) 1993-08-31
IT1215666B (it) 1990-02-22
GR871860B (en) 1988-05-10
HK5593A (en) 1993-02-05
JPS63208522A (ja) 1988-08-30
SE467910B (sv) 1992-10-05
CS265249B2 (en) 1989-10-13
ES2008951A6 (es) 1989-08-16
NL8800025A (nl) 1988-08-01
DK166404B1 (da) 1993-05-17
ATA341687A (de) 1989-01-15
YU46689B (sh) 1994-04-05
SG114792G (en) 1992-12-24
DE3740588C2 (de) 1996-07-11
FI89006C (fi) 1993-08-10
AU606361B2 (en) 1991-02-07
SE8800036L (sv) 1988-07-10
FI875122A0 (fi) 1987-11-19
GB2199746A (en) 1988-07-20
GB8725875D0 (en) 1987-12-09
FR2609396B1 (fr) 1993-01-29
OA08796A (fr) 1989-03-31
HU199686B (en) 1990-03-28
YU2388A (en) 1989-10-31
FR2609396A1 (fr) 1988-07-15
SU1575942A3 (ru) 1990-06-30
SE8800036D0 (sv) 1988-01-08
US4808617A (en) 1989-02-28
GB2199746B (en) 1990-10-24
FI875122A (fi) 1988-07-10
DD264614A5 (de) 1989-02-08
FI89006B (fi) 1993-04-30
HUT46223A (en) 1988-10-28
CH676202A5 (it) 1990-12-28
BE1002114A3 (fr) 1990-07-10
CY1679A (en) 1993-10-10

Similar Documents

Publication Publication Date Title
NZ224129A (en) Cephalosporin derivatives and pharmaceutical compositions
CY1663A (en) Cephalosporin salts and injectable compositions
IL84346A (en) Antibiotic compositions comprising lyophilized or precipitated cephalosporin zwitterion and salt combination
AU628664B2 (en) Cephalosporin compound and pharmaceutical composition thereof
GB2179936B (en) Cephalosporin salts and injectable compositions
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
IL87364A0 (en) Water-soluble antibiotic composition containing cephem derivatives and processes for the preparation thereof
NZ224130A (en) Cephalosporin derivatives and pharmaceutical compositions
EP0315997A3 (en) Cephalosporin compounds and antibacterial agents
NZ225383A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ228403A (en) Cephalosporin derivatives and pharmaceutical compositions
IL71499A0 (en) Improvements in or relating to benzothienyl cephalosporin antibiotics
GB8518124D0 (en) Cephalosporin antibiotics
NZ224997A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ210761A (en) Cephalosporin derivatives and pharmaceutical compositions
GB8627404D0 (en) Cephalosporin antibiotics
NZ216624A (en) Cephalosporins and pharmaceutical compositions
GB8629677D0 (en) Cephalosporin antibiotics
GB8526900D0 (en) Cephalosporin antibiotics
GB8526901D0 (en) Cephalosporin antibiotics
JPS6442491A (en) Cephalosporin derivative and manufacture
NZ221951A (en) Substituted cephalosporin derivatives and pharmaceutical compositions
NZ222461A (en) Temperature stable cephalosporin zwitterion and salt composition prepared by lyophilisation or cosolvent precipitation
IE872021L (en) Cephalosporins and derivatives
GB8604179D0 (en) Cephalosporin antibiotics

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired